Home Applications 761175 Application 761175
Type BLA
Sponsor BIOCON BIOLOGICS INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761175 Jobevne bevacizumab-nwgd 351(k) Biosimilar Rx 2026-06-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 JOBEVNE BEVACIZUMAB-NWGD INJECTABLE;INJECTION 100MG/4ML Yes No 002 JOBEVNE BEVACIZUMAB-NWGD INJECTABLE;INJECTION 400MG/16ML Yes No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join JOBEVNE BEVACIZUMAB-NWGD Biocon Biologics Inc. 70ab1de6-fb68-aee4-a6cb-f9a0f146687f 2026-03-11 Warnings, Adverse reactions Exact identifier application number: BLA761175
Documents# Document, Submission type, Date table Document Submission type Date 82014 ORIG 2025-04-25 81927 ORIG 2025-04-16